glucose, (beta-d)-isomer has been researched along with Polycystic Ovarian Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Cui, L; Huang, L; Xiao, Z; Xiong, X | 1 |
| Tan, Y; Wang, X; Zhou, J; Zhu, M | 1 |
| Davenport, K; Everman, SJ; Logan, MK; Pruett, JE; Romero, DG; Torres Fernandez, ED; Vinson, RM; Yanes Cardozo, LL; Ye, SA | 1 |
| Bellanger, D; Chappell, N; Elkind-Hirsch, KE; Seidemann, E; Storment, J | 1 |
| Jin, X; Ong, M; Peng, J; Qu, X | 1 |
| Cheng, J; Jin, X; Johnson, M; Lao, W; Ong, M; Qu, X; Tan, Y | 1 |
| Abbas, J; Atkin, SL; Deshmukh, H; Javed, Z; Khan, AY; Kilpatrick, ES; Papageorgiou, M; Qamar, U; Rigby, AS; Sathyapalan, T | 1 |
| Chang, ZP; Cheng, Y; Feng, XJ; Guo, YT; Hou, RG; Liu, JJ; Shao, YY; Song, Y; Xu, D; Zhang, JP | 1 |
2 review(s) available for glucose, (beta-d)-isomer and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Sodium-glucose cotransporter 2 inhibitor ameliorates high fat diet-induced hypothalamic-pituitary-ovarian axis disorders.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Female; Glucose; Glucosides; Humans; Hypoglycemic Agents; Polycystic Ovary Syndrome; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Topics: Androgens; Berberine; Drugs, Chinese Herbal; Female; Ginsenosides; Glucosides; Humans; Insulin Resistance; Monoterpenes; Phenanthrenes; Phytotherapy; Polycystic Ovary Syndrome; Resveratrol; Stilbenes; Theca Cells | 2017 |
2 trial(s) available for glucose, (beta-d)-isomer and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult | 2021 |
Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study.
Topics: Adolescent; Adult; Anthropometry; Benzhydryl Compounds; Body Composition; Cardiovascular Diseases; Drug Administration Schedule; Female; Glucosides; Hormones; Humans; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2019 |
4 other study(ies) available for glucose, (beta-d)-isomer and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway
Topics: Animals; Dehydroepiandrosterone; Disease Models, Animal; Estrous Cycle; Female; Glucosides; Monoterpenes; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2021 |
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Benzhydryl Compounds; Dihydrotestosterone; Disease Models, Animal; Female; Glucosides; Heart; Hyperandrogenism; Polycystic Ovary Syndrome; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells.
Topics: Animals; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Dexamethasone; Down-Regulation; Female; Glucosides; Mice; Monoterpenes; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone; Theca Cells | 2019 |
Comparative pharmacokinetics and metabolites study of seven major bioactive components of Shaoyao-Gancao decoction in normal and polycystic ovary syndrome rats by ultra high pressure liquid chromatography with tandem mass spectrometry.
Topics: Administration, Oral; Animals; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Female; Flavanones; Glucosides; Glycyrrhetinic Acid; Glycyrrhizic Acid; Monoterpenes; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2019 |